INSERT INTO sites(host) VALUES('') 1045: Access denied for user 'www-data'@'localhost' (using password: NO) Estimated Worth $139,794 - MYIP.NET Website Information
Welcome to!
 Set MYIP as homepage      


Web Page Information

Meta Description:
Meta Keywords:
sponsored links:
sponsored links:

Traffic and Estimation


Website Ranks

Alexa Rank:
Google Page Rank:
Sogou Rank:
Baidu Cache:

Search Engine Indexed

Search EngineIndexedLinks

Server Data

Web Server:
IP address:    

Registry information

ICANN Registrar:
Name Server:
Whois Server:

Alexa Rank and trends

Traffic: Today One Week Avg. Three Mon. Avg.
Unique IP:

More ranks in the world

Users from these countries/regions

Where people go on this site

Alexa Charts

Alexa Reach and Rank

Whois data

Who is at


Registry Domain ID: 2033159_DOMAIN_COM-VRSN

Registrar WHOIS Server:

Registrar URL:

Updated Date: 2018-10-30T23:05:55Z

Creation Date: 1995-10-31T05:00:00Z

Registry Expiry Date: 2028-10-30T04:00:00Z

Registrar: Network Solutions, LLC

Registrar IANA ID: 2

Registrar Abuse Contact Email: abuse

Registrar Abuse Contact Phone: +1.8003337680

Domain Status: clientTransferProhibited

Name Server:

Name Server:

Name Server:

Name Server:

Name Server:

Name Server:

DNSSEC: unsigned

URL of the ICANN Whois Inaccuracy Complaint Form:

>>> Last update of whois database: 2019-02-13T19:43:05Z <<<

For more information on Whois status codes, please visit

The expiration date displayed in this record is the date the

registrar's sponsorship of the domain name registration in the registry is

currently set to expire. This date does not necessarily reflect the expiration

date of the domain name registrant's agreement with the sponsoring

registrar. Users may consult the sponsoring registrar's Whois database to

view the registrar's reported date of expiration for this registration.

You are not authorized to access or query our Whois

database through the use of electronic processes that are high-volume and

automated except as reasonably necessary to register domain names or

modify existing registrations; the Data in VeriSign Global Registry

Services' ("VeriSign") Whois database is provided by VeriSign for

information purposes only, and to assist persons in obtaining information

about or related to a domain name registration record. VeriSign does not

guarantee its accuracy. By submitting a Whois query, you agree to abide

by the following terms of use: You agree that you may use this Data only

for lawful purposes and that under no circumstances will you use this Data

(1) allow, enable, or otherwise support the transmission of mass

unsolicited, commercial advertising or solicitations via e-mail, telephone,

or facsimile; or (2) enable high volume, automated, electronic processes

that apply to VeriSign (or its computer systems). The compilation,

repackaging, dissemination or other use of this Data is expressly

prohibited without the prior written consent of VeriSign. You agree not to

use electronic processes that are automated and high-volume to access or

query the Whois database except as reasonably necessary to register

domain names or modify existing registrations. VeriSign reserves the right

to restrict your access to the Whois database in its sole discretion to ensure

operational stability. VeriSign may restrict or terminate your access to the

Whois database for failure to abide by these terms of use. VeriSign

reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and


Front Page Thumbnail

sponsored links:

Front Page Loading Time

Keyword Hits (Biger,better)

Other TLDs of deerfield

TLDs Created Expires Registered

Similar Websites


Search Engine Spider Emulation

Title: Deerfield | Deerfield Management
Description:Deerfield Advancing healthcare through investment, information and philanthropy. Our approaches to capital funding are uniquely flexible to give companies the leverage they need to advance their business goals and set new standards for the healthcare industry.
Keywords:Deerfield, Deerfield Management, Deerfield Institute, Deerfield Foundation, Deerfield Investments, Deerfield financings, Deerfield Healthcare
Deerfield | Deerfield Management
Advancing healthcare reg; through investment,
information and philanthropy.
We believe our approaches to capital funding are uniquely flexible to give companies the leverage they need to advance their business goals and set new standards for the healthcare industry.
Our partners benefit from our well researched understanding of the healthcare ecosystem, enabling them to identify new opportunities and optimally position their products and services.
The Deerfield Foundation, created to give our people more opportunities to help others, pursues philanthropic initiatives with a special focus on children and medical innovation.
Deerfield Management Advanced Healthcare Initiatives Globally Through Academic Collaborations, Publications, and Philanthropy - February 2019Stelexis Therapeutics Closes $43 million Series A to Expand Novel Platform Focused on Cancer Interception - January 2019Deerfield Newsletter 鈥 Revisiting Biosimilars: A Closer Look at the Commercial Barriers, New and Noteworthy Approvals from 2018, Peer-Reviewed Abstracts, IP Corner, Caught Our Eye, Deerfield Foundation, News You May Have Missed, Meet the Associates, Deerfield Employees Volunteer for Habitat for Humanity - January 2019Shine and Deerfield Close $150 Million Financing Commitment to Support Diagnostic and Therapeutic Medical Isotope Manufacturing - November 2018Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Center for Protein Degradation - November 2018UNC鈥怌hapel Hill and Deerfield Management announce the creation of Pinnacle Hill to accelerate the discovery of new medicines - October 2018Deerfield Provides $125 million Debt Financing to Tris Pharma - October 2018Deerfield Newsletter 鈥 Inaugural Approvals for RNA-Based Medicine, New Story Reignites Old Debate on Conflict of Interest, Peer-Reviewed Abstracts, IP Corner, Caught Our Eye, Deerfield Foundation, News You May Have Missed, News From Our Foundation Partners, Meet the Associates - October 2018Deerfield and Stan Rowe Create a Next Generation Therapeutic Device Incubator, NXT Biomedical - September 2018University of California San Diego and Deerfield Management Create Poseidon Innovation to Advance Disease-Curing Therapeutics - September 2018Bridge Medicines Enters Agreement with Memorial Sloan Kettering to Develop Kidney鈥怱pecific Delivery Platform for the Treatment of Acute Kidney Injury - July 2018Deerfield Newsletter 鈥 Interpreting Clinical Trial Results With A Healthy Dose Of Skepticism, Deerfield and Oxeon Cohost Third Annual Break Into The Boardroom Program, Peer-Reviewed Abstracts, IP Corner, Caught Our Eye, Deerfield Foundation, News You May Have Missed, News From Our Foundation Partners - June 2018Deerfield invested in Appello Pharmaceuticals, Inc. - June 2018Ablexis Targets Market Expansion Opportunities for AlivaMab Mouse Following Acquisition by Deerfield Management and the Founding of AlivaMab Discovery Services - June 2018Northwestern University and Deerfield Management launch Lakeside Discovery to provide tomorrow鈥檚 solutions in healthcare - May 2018Deerfield Invested in InCarda Therapeutics - May 2018Deerfield Newsletter 鈥 Taking Inventory of Amazon鈥檚 Potential Moves into Healthcare, Labs Recalibrate to new Normal Under Pama Prices, Peer-Reviewed Abstracts, IP Corner, Deerfield Foundation - April 2018Deerfield Leads Investment of up to $50 Million in Sollis Therapeutics鈥 Innovative Solution for Sciatica Pain - April 2018Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer - April 2018Deerfield invested in Arvinas, Inc. - March 2018Deerfield Management and Vanderbilt University announce the launch of Ancora Innovation - March 2018Deerfield Commits $36 Million to Advance Dracen鈥檚 Novel Immuno-Metabolism Pipeline - March 2018Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development - March 2018DFB Healthcare Acquisitions Corp. Closes $250 Million Initial Public Offering - February 2018Deerfield acquires ReMed alongside Baird Capital - February 2018Broad Institute and Deerfield Management Announce the Advancement of Two Partnership Projects - February 2018Deerfield Continues its Commitment to Advancing Healthcare Through its Publication Activities - January 2018Bluefield Innovations Pursues Broadly Applicable Cancer Target - January 2018Deerfield invests in Concert Genetics - December 2017Deerfield invests in Quartet Health - December 2017Deerfield Discovers Gender Affects Treatment and Outcome in Abdominal Aortic Aneurysm - December 2017Deerfield Newsletter 鈥 CAR-T in Context, New and Noteworthy Approvals from 2017, Deerfield Foundation, Meet the Associates, IP Corner - December 2017Deerfield Supports Melinta Therapeutics Acquisition of The Medicines Company鈥檚 Infectious Disease Business with a $240 million Commitment to Melinta and a $100 million Commitment to The Medicines Company - November 2017Deerfield and The Johns Hopkins University Announce Collaboration to Catalyze Early Stage Therapeutic Research - November 2017Broad Institute and Deerfield Management launch innovative partnership to tackle serious unmet medical needs - October 2017Wall Street Journal publishes, "Deerfield Management to Fund Biology Research at Broad Institute" by Jonathan D. Rockoff - October 2017Deerfield Management Completes Acquisition of Adeptus Health - October 2017Deerfield Newsletter 鈥 Biosimilars: Separating Hype from Reality, Rethinking the Sales Force Business Model in a Dramatically Changing Environment, Deerfield Foundation, From our Foundation Partners, Meet the Associates, IP Corner - September 2017Deerfield Invests in MIVI Neuroscience - August 2017Deerfield led funding for Proteon Therapeutics, Inc. - June 2017Deerfield Newsletter 鈥 Perceptions and Realities of the Drug Pricing Debate, How Drug Pricing May Find Itself in the Crosshairs of the Legislative Agenda , Deerfield Foundation, Meet the Fellows, IP Corner - June 2017Deerfield Invests in Phoenix Nuclear Labs, LLC - April 2017Adeptus Health and Deerfield Join Forces to Enable High Quality Emergency Care - April 2017Deerfield Management Company Invests $170 Million to Advance Aortic Disorder Treatment - April 2017Deerfield Newsletter 鈥 Understanding the Policy Debate Around the ACA, Break into the Boardroom Program, Deerfield Foundation, Meet the Fellows, Get to Know Some Deerfield鈥檈rs, IP Corner - March 2017Deerfield Hires Vicki Gaddy as Head of Human Resource Strategy and Talent Acquisition - February 2017Deerfield Continues to Advance Healthcare Through the Publication of Novel Findings - January 2017MD Anderson and Deerfield Management create Vescor LLC to develop novel therapeutics based on inhibiting autophagy for treatment of specific cancers - January 2017Deerfield Newsletter - Traveling A New Path for Innovation with Bridge Medicines 鈥 Meet the Fellows 鈥 Get to Know Some Deerfield鈥檈rs 鈥 IP Corner - December 2016Deerfield Leads Series A Investment in Chondrial Therapeutics - November 2016Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept - October 2016Deerfield Announces Strategic Collaboration with Peking Union School of Public Health to Advance Healthcare in China - October 2016Deerfield Leads Series D Investment in SentreHEART - October 2016Deerfield Invests in FOG Pharmaceuticals, Inc. - October 2016Deerfield Newsletter 鈥 Gene Therapy 鈥 The Price is Right, Board Diversity, IP Corner - September 2016Deerfield Management Company Completes Sale of Veterinary Practice Partners to Pamlico Capital - August 2016Deerfield Announces Lead Investment in Visionary Anti-Fibrotic Company Blade Therapeutics - June 2016Deerfield Newsletter - Electronic Health Records, Biomedical Innovation, IP Corner - June 2016Deerfield Supports Patient Care Advancing Ophthalmology Company Graybug Vision - May 2016Deerfield Invests $80 million in Leading Population Health Services Company - April 2016Deerfield Leads $34 Million Investment in Lumos Pharma - April 2016Deerfield Invests in Potential Treatment Transforming Electrophysiology Company - March 2016Deerfield Invests in Transformative Microbiome Platform - February 2016Deerfield Management and Oxeon Unlock the Power of Women in the Boardroom - February 2016Deerfield Invests in Ribon Therapeutics - February 2016Deerfield Advances Healthcare Through the Publication of Novel Findings - January 2016Deerfield Leads Investment in Advantia Health - January 2016Deerfield Announces Partnership with Recovery Centers of America - December 2015Deerfield Leads Series 1-A financing for Hallux - December 2015Deerfield Invests in Series A for Aziyo - November 2015Deerfield Management Announces Partnership with Gregory Sorensen and Deerfield Imaging - October 2015Deerfield Makes $50 Million Commitment to AAC Holdings to Expand Clinical Care and Treatment with Additional $50 Million Incremental Facility - October 2015Deerfield Leads Funding in Creation of Akari Therapeutics - September 2015Deerfield Invests in Headspace - August 2015Deerfield Invests $20 million in Editas Medicine - August 2015Deerfield Invests in Rhythm Metabolic - August 2015Deerfield Launches $550 Million Healthcare Venture-Capital Fund - July 2015How to End the Regulatory Slowdown for New Antibiotics - WSJ - July 2015Deerfield Invests in TriNetX - July 2015Deerfield Invests in CytomX Therapeutics - June 2015Deerfield Invests in NeoChord - June 2015Deerfield Announces a $300 million commitment to create and build Aralez Pharmaceuticals Ltd. - June 2015Deerfield supports EuropaBio selected Most Innovative European Biotech SME Awards - June 2015Deerfield Commits to Invest $10 million in Vital Access - May 2015Deerfield Invests in Shockwave Medical - May 2015Deerfield Leads Series B Preferred Financing for Cureatr - May 2015Deerfield Invests $48 million in Trinity Biotech - April 2015Deerfield and EuropaBio Publish a Report on Regulatory and HTA Scientific Advice for Small and Medium Enterprises - March 2015Deerfield Provides Debt Facility to Depomed - March 2015Improving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use (Health Affair: Feb 2015) - February 2015Deerfield Institute Announces the Publication of 鈥淚mproving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use鈥 in the February issue of Health Affairs Journal鈥 - February 2015Deerfield Management Company Invests in SteadyMed Ltd. - January 2015Deerfield Finances Pioneer in 3D Printing for Pharmaceuticals - January 2015Deerfield Management Company Invests in REGENXBIO Inc. - January 2015Deerfield Invests in Essa Pharmaceuticals - January 2015Deerfield Invests in Global Blood Therapeutics - January 2015Deerfield Invests in Audentes Therapeutics - December 2014Deerfield Invests in Conventus Orthopaedics, Inc. - December 2014Deerfield Management Company Invests $50 million in Alimera Sciences, Inc. - November 2014Deerfield Management Company Announces a $5 million investment in MedAvail Technologies, Inc. - October 2014Deerfield Management Company Announces a $125 million Term Sheet with SHINE Medical Technologies, Inc. - October 2014Deerfield Management Announces a $125 million Facility with Aerie Pharmaceuticals - September 2014Deerfield Announces a $4.5 million Venture Capital Investment in Epion Health - July 2014Deerfield Management Company Announces up to a $60 million Facility with KemPharm, Inc. - June 2014Deerfield Invests in Spark Therapeutics - May 2014Deerfield Invests in Proteon Therapeutics, Inc. - May 2014Deerfield Invests $27.5mm in OMNIlife science, Inc. - April 2014Deerfield Announces New $1.6 Billion Private Investment Fund to Advance Healthcare - April 2014Deerfield Announces a $35 million Investment Commitment for Cytomedix, Inc. - March 2014Deerfield Announces $15 Million Investment in Wellfount - March 2014Deerfield Provides up to $250 million in Acquisition Financing to Horizon Pharma - March 2014Deerfield Announces up to a $50 million Investment in Alphatec Spine - March 2014Deerfield Provides a flexible financing of up to $100 million to Infinity Pharmaceuticals - February 2014Deerfield Announces up to $50 Million Investment in Fidelis SeniorCare - January 2014Deerfield Invests $160 Million in MannKind Corporation - July 2013Deerfield Announces $35 Million Investment in WorldOne - April 2013Deerfield Announces $30 Million Investment in Discovery Labs - February 2013Deerfield Announces Financing Transaction with Flamel Technologies - February 2013Deerfield Completes $20.5 Million Financing in Pacific Biosciences - February 2013Deerfield Management Announces Appointment of Jonathan S. Leff as Partner and Chairman of the Deerfield Institute - December 2012Deerfield Provides a flexible $50 million facility to MAKO Surgical - May 2012Deerfield Divests topical herpes drug Denavir to Renaissance Pharmaceuticals - October 2010
Who We Are
Healthcare Humor
A Hybrid Approach for Prediction of Event Times in Double-Blind Clinical Trials - July 2018Predictors of laparoscopic hysterectomy for leiomyoma surgical removal in the United States - May 2018Analysis of Success Rates for the Center for Medicare and Medicaid鈥檚 New Technology Add-On Payment Program - May 2018Trends in isolated mitral valve surgery: the changing risk profile of patients and outcomes - April 2018The importance of emerging transcatheter mitral valve technologies in cost-effectiveness and post-procedure outcomes - April 2018Deerfield Continues its Commitment to Advancing Healthcare Through its Publication Activities - January 2018Persisting disparities between sexes in outcomes of ruptured abdominal aortic aneurysm hospitalizations - December 2017Treatment Sequencing in Advanced BRAF-Mutant Melanoma Patients: Current Practice in the United States - November 2017Variability in the therapeutic management of advanced ovarian cancer patients: a five-country survey of oncologists - November 2017Is it time for the weighted log-rank test to play a more important role in confirmatory trials? - October 2017Reducing waiting time and raising outpatient satisfaction - an interrupted time series study - September 2017Nationwide trends of clinical characteristics and economic burden of emergency department visits due to acute ischemic stroke - September 2017Global perspective on colonoscopy use for colorectal cancer screening: a multi-country survey of practicing colonoscopists - July 2017Trends in the molecular diagnosis of lung cancer, results from an online market research survey - July 2017Adverse drug reaction early warning using user search data - July 2017Investment and incentives in 21st Century pharmaceutical research in Europe: the cost of opportunity - March 2017Considerations on bringing warehoused HCV patients into active care following interferon-free, direct-acting antiviral drug approval - March 2017Deerfield Continues to Advance Healthcare Through the Publication of Novel Findings - January 2017Consumer satisfaction with tertiary healthcare in China: findings from the 2015 China National Patient Survey - January 2017Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United-States, 2012-2015 - December 2016Recent Trends in Percutaneous Coronary Intervention Volume in the United States: Analysis of HCUP-NIS, 2010-2013 - December 2016Press releases for Phase 2 clinical trial topline results: Have the objective pre-specified efficacy results been disclosed? - December 2016Communication practices and awareness of resources for acromegaly patients among endocrinologists - December 2016A Brief Patent Primer - December 2016Epidemiology of Chronic Kidney Disease and Predictors of Hyperkalemia: Analysis of Nhanes 2007-2014 - November 2016Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization - September 2016Epidemiology of Low Dose Aspirin Use for Primary and Secondary Prevention of Cardiovascular Disease - July 2016Mitral valve disease in the United States: retrospective analysis of hospitalizations and surgical procedures using the National Inpatient Sample (World Congress on Heart Disease abstract) - July 2016Building a Drug Development Database: Challenges in Reliable Data Availability - July 2016Modeling the Burden of Abdominal Aortic Aneurysm in the USA in 2013 - June 2016Idiopathic pulmonary fibrosis: physician's perceptions of patient treatment with recently approved drugs - April 2016Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists - March 2016The Prevalence of Peyronie's Disease in the United States: A Population-Based Study - February 2016Self-reported physician practices in pulmonary arterial hypertension: diagnosis, assessment, and referral - December 2015Read our latest article on fertility management - December 2015Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue? - December 2015A novel design for randomized immuno-oncology clinical trials with potentially delayed treatment effects - November 2015Prize winning abstract on AAA presented at Annual meeting of American College of Epidemiology - September 2015The pursuit of balance: an overview of covariate-adaptive randomization techniques in clinical trials - August 2015Design of clinical trials with failure-time endpoints and interim analyses: an update after fifteen years - May 2015Improving pharmaceutical innovation by building a more comprehensive database on drug development and use - February 2015
Contact Us
漏 2019 Deerfield. All rights reserved | Contact | Terms of Use | Privacy Policy

Updated Time

Friend links: ProxyFire    More...
Site Map 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 250 300 350 400 450 500 550 600 610 620 630 640 650 660 670 680 690 700 710 720 730 740 750
TOS | Contact us
© 2009 Dev by MYIP Elapsed:1.636ms